DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+6.5%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$308M
AUM Growth
+$308M
(-11%)
Cap. Flow
-$26.2M
Cap. Flow
% of AUM
-8.51%
Top 10 Holdings %
Top 10 Hldgs %
52.97%
Holding
98
New
10
Increased
19
Reduced
20
Closed
18
Top Buys
| 1 |
IDEAYA Biosciences
IDYA
|
$4.17M |
| 2 |
Arcturus Therapeutics
ARCT
|
$3.46M |
| 3 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$2.6M |
| 4 |
Ascendis Pharma
ASND
|
$2.31M |
| 5 |
89bio
ETNB
|
$2.31M |
Top Sells
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$12.7M |
| 2 |
Kura Oncology
KURA
|
$7.82M |
| 3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$3.85M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$3.8M |
| 5 |
Compugen
CGEN
|
$3.7M |
Sector Composition
| 1 | Healthcare | 83.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mersana Therapeutics
MRSN
$36.5M
| $2.84M | 0.92% | 152,763 -117,400 | -43% | -$2.19M |
|
|
27
89bio
ETNB
$1.34B
| $2.84M | 0.92% | 110,478 +90,000 | +439% | +$2.31M |
|
28
Liquidia Corp
LQDA
$2.38B
| $2.83M | 0.92% | 575,000 +25,000 | +5% | +$123K |
|
|
OTIC
29
DELISTED
Otonomy, Inc.
OTIC
| $2.79M | 0.91% | 689,100 +219,965 | +47% | +$891K |
|
|
BEAT
30
DELISTED
BioTelemetry, Inc.
BEAT
| $2.76M | 0.9% | 60,500 | – | – |
|
31
Viking Therapeutics
VKTX
$3.04B
| $2.62M | 0.85% | 450,900 | – | – |
|
32
KalVista Pharmaceuticals
KALV
$678M
| $2.62M | 0.85% | 208,054 -14,398 | -6% | -$181K |
|
|
TBIO
33
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $2.6M | 0.84% | +190,930 | New | +$2.6M |
|
34
Accuray
ARAY
$157M
| $2.58M | 0.84% | 1,074,300 +400,000 | +59% | +$960K |
|
35
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.57M | 0.84% | 749,051 +5,000 | +0.7% | +$17.2K |
|
36
Neuronetics
STIM
$220M
| $2.41M | 0.78% | 495,772 | – | – |
|
|
KDMN
37
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.21M | 0.72% | 563,564 +10,000 | +2% | +$39.2K |
|
|
SPPI
38
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $2.1M | 0.68% | +514,891 | New | +$2.1M |
|
39
MEI Pharma
MEIP
$160M
| $2.08M | 0.68% | 666,000 +611,000 | +1,111% | +$1.91M |
|
|
40
Compugen
CGEN
$132M
| $1.87M | 0.61% | 115,202 -227,844 | -66% | -$3.7M |
|
|
ISEE
41
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.82M | 0.59% | 322,500 -35,000 | -10% | -$197K |
|
|
BLUE
42
DELISTED
bluebird bio
BLUE
| $1.63M | 0.53% | 30,273 | – | – |
|
|
43
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.52M | 0.49% | 102,713 -257,287 | -71% | -$3.8M |
|
44
Alector
ALEC
$238M
| $1.48M | 0.48% | 140,000 | – | – |
|
|
HARP
45
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.45M | 0.47% | 85,119 | – | – |
|
46
Johnson & Johnson
JNJ
$427B
| $1.4M | 0.45% | 9,400 | – | – |
|
|
ALPN
47
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.3M | 0.42% | +148,260 | New | +$1.3M |
|
48
Arcus Biosciences
RCUS
$1.13B
| $1.24M | 0.4% | 72,100 | – | – |
|
49
Larimar Therapeutics
LRMR
$310M
| $1.2M | 0.39% | 79,155 -47,106 | -37% | -$715K |
|
|
50
Kura Oncology
KURA
$686M
| $1.2M | 0.39% | 39,019 -255,241 | -87% | -$7.82M |
|